| Mepha Pharma AG - Ropinirol-Mepha retard 2 mg, Retardtabletten | | 62614 | | 01 | | Ropinirol-Mepha retard 2 mg | | Retardtabletten | | N04BC04 | | Ropinirole | | 18.06.2013 | | |
| | Composition | | ropinirolum 2 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum B, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: lactosum monohydricum 1.8 mg, hypromellosum, triacetinum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 0.538 mg. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Ropinirol | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Ropinirol | 2 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Ammonio Methacrylatis Copolymerum B | | | | Copovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 1.8 mg | Überzug | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 21 Tablet(s) | | | B | | Yes | | 002 | 28 Tablet(s) | 16.16 | 34.00 | B | SL | No |
|
|
